Long Beach, California 90806


Purpose:

The investigators intend to perform a large randomized trial using standardized obstetrical and anesthetic practice at a single institution to determine the effects of patient controlled epidural analgesia on obstetrical and neonatal outcomes.


Study summary:

Women in their first pregnancy in spontaneous labor desiring epidural anesthesia will be randomized to one of three groups. Each group will initially be given intrathecal bolus. Before and 30 minutes after the initial bolus, the patient's verbal pain score will be recorded. The continuous epidural infusion group (Group I) will be started immediately on a continuous pump infusion.They will also have the opportunity to give a PCA bolus Finally, the patient controlled epidural group (Group III) will be able to give a bolus every 20 minutes with no continuous infusion. Each group will also be allowed 2 boluses,by the anesthesia staff in the event that their pain is not controlled by the indicated study medication. An hourly evaluation of verbal pain score and maternal mobility will be recorded. After delivery, obstetrical outcomes, neonatal outcomes, anesthesia interventions, and patient satisfaction questionnaires will then be collected.


Criteria:

Inclusion Criteria: - Early labor - Nulliparous Exclusion Criteria: - Inductions - Breech - Contraindications to regional anesthesia


NCT ID:

NCT00810914


Primary Contact:

Principal Investigator
Michael Haydon, MD
Memorial care Health Sytem Physcian

Christine Preslicka, RN
Phone: 562-933-2755
Email: cpreslicka@memorialcare.org


Backup Contact:

N/A


Location Contact:

Long Beach, California 90806
United States

Christine Preslicka, RN
Phone: 562-933-2750
Email: cpreslicka@memorialcare.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.